TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Metagenomics in Healthcare Market - Global Outlook and Forecast 2022-2028

Metagenomics in Healthcare Market - Global Outlook and Forecast 2022-2028

  • Category:Life Sciences
  • Published on : 21 July 2022
  • Pages :60
  • Formats:
  • Report Code:SMR-7219066
OfferClick for best price

Best Price: $2600

MetagenomicsHealthcare Market Size, Share 2022


Metagenomics is the study of genetic material recovered directly from environmental samples.

This report contains market size and forecasts of Metagenomics in Healthcare in Global, including the following market information:

Global Metagenomics in Healthcare Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Metagenomics in Healthcare market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Sample Extraction Kits Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Metagenomics in Healthcare include Illumina, QIAGEN, PerkinElmer, Thermo Fisher Scientific and Oxford Nanopore Technologies, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Metagenomics in Healthcare companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Metagenomics in Healthcare Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Metagenomics in Healthcare Market Segment Percentages, by Type, 2021 (%)

Sample Extraction Kits

Metagenomics Kits

Global Metagenomics in Healthcare Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Metagenomics in Healthcare Market Segment Percentages, by Application, 2021 (%)

Pharmaceutical Industries

Biotechnology Companies

Pathology Laboratories

Academic and Research Laboratories

Others

Global Metagenomics in Healthcare Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Metagenomics in Healthcare Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Metagenomics in Healthcare revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Metagenomics in Healthcare revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Illumina

QIAGEN

PerkinElmer

Thermo Fisher Scientific

Oxford Nanopore Technologies

Report Attributes Report Details
Report Title Metagenomics in Healthcare Market - Global Outlook and Forecast 2022-2028
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 60 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Introduction to Research & Analysis Reports
1.1 Metagenomics in Healthcare Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Metagenomics in Healthcare Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Metagenomics in Healthcare Overall Market Size
2.1 Global Metagenomics in Healthcare Market Size: 2021 VS 2028
2.2 Global Metagenomics in Healthcare Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Metagenomics in Healthcare Players in Global Market
3.2 Top Global Metagenomics in Healthcare Companies Ranked by Revenue
3.3 Global Metagenomics in Healthcare Revenue by Companies
3.4 Top 3 and Top 5 Metagenomics in Healthcare Companies in Global Market, by Revenue in 2021
3.5 Global Companies Metagenomics in Healthcare Product Type
3.6 Tier 1, Tier 2 and Tier 3 Metagenomics in Healthcare Players in Global Market
3.6.1 List of Global Tier 1 Metagenomics in Healthcare Companies
3.6.2 List of Global Tier 2 and Tier 3 Metagenomics in Healthcare Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Metagenomics in Healthcare Market Size Markets, 2021 & 2028
4.1.2 Sample Extraction Kits
4.1.3 Metagenomics Kits
4.2 By Type - Global Metagenomics in Healthcare Revenue & Forecasts
4.2.1 By Type - Global Metagenomics in Healthcare Revenue, 2017-2022
4.2.2 By Type - Global Metagenomics in Healthcare Revenue, 2023-2028
4.2.3 By Type - Global Metagenomics in Healthcare Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Metagenomics in Healthcare Market Size, 2021 & 2028
5.1.2 Pharmaceutical Industries
5.1.3 Biotechnology Companies
5.1.4 Pathology Laboratories
5.1.5 Academic and Research Laboratories
5.1.6 Others
5.2 By Application - Global Metagenomics in Healthcare Revenue & Forecasts
5.2.1 By Application - Global Metagenomics in Healthcare Revenue, 2017-2022
5.2.2 By Application - Global Metagenomics in Healthcare Revenue, 2023-2028
5.2.3 By Application - Global Metagenomics in Healthcare Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Metagenomics in Healthcare Market Size, 2021 & 2028
6.2 By Region - Global Metagenomics in Healthcare Revenue & Forecasts
6.2.1 By Region - Global Metagenomics in Healthcare Revenue, 2017-2022
6.2.2 By Region - Global Metagenomics in Healthcare Revenue, 2023-2028
6.2.3 By Region - Global Metagenomics in Healthcare Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Metagenomics in Healthcare Revenue, 2017-2028
6.3.2 US Metagenomics in Healthcare Market Size, 2017-2028
6.3.3 Canada Metagenomics in Healthcare Market Size, 2017-2028
6.3.4 Mexico Metagenomics in Healthcare Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Metagenomics in Healthcare Revenue, 2017-2028
6.4.2 Germany Metagenomics in Healthcare Market Size, 2017-2028
6.4.3 France Metagenomics in Healthcare Market Size, 2017-2028
6.4.4 U.K. Metagenomics in Healthcare Market Size, 2017-2028
6.4.5 Italy Metagenomics in Healthcare Market Size, 2017-2028
6.4.6 Russia Metagenomics in Healthcare Market Size, 2017-2028
6.4.7 Nordic Countries Metagenomics in Healthcare Market Size, 2017-2028
6.4.8 Benelux Metagenomics in Healthcare Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Metagenomics in Healthcare Revenue, 2017-2028
6.5.2 China Metagenomics in Healthcare Market Size, 2017-2028
6.5.3 Japan Metagenomics in Healthcare Market Size, 2017-2028
6.5.4 South Korea Metagenomics in Healthcare Market Size, 2017-2028
6.5.5 Southeast Asia Metagenomics in Healthcare Market Size, 2017-2028
6.5.6 India Metagenomics in Healthcare Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Metagenomics in Healthcare Revenue, 2017-2028
6.6.2 Brazil Metagenomics in Healthcare Market Size, 2017-2028
6.6.3 Argentina Metagenomics in Healthcare Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Metagenomics in Healthcare Revenue, 2017-2028
6.7.2 Turkey Metagenomics in Healthcare Market Size, 2017-2028
6.7.3 Israel Metagenomics in Healthcare Market Size, 2017-2028
6.7.4 Saudi Arabia Metagenomics in Healthcare Market Size, 2017-2028
6.7.5 UAE Metagenomics in Healthcare Market Size, 2017-2028
7 Players Profiles
7.1 Illumina
7.1.1 Illumina Corporate Summary
7.1.2 Illumina Business Overview
7.1.3 Illumina Metagenomics in Healthcare Major Product Offerings
7.1.4 Illumina Metagenomics in Healthcare Revenue in Global Market (2017-2022)
7.1.5 Illumina Key News
7.2 QIAGEN
7.2.1 QIAGEN Corporate Summary
7.2.2 QIAGEN Business Overview
7.2.3 QIAGEN Metagenomics in Healthcare Major Product Offerings
7.2.4 QIAGEN Metagenomics in Healthcare Revenue in Global Market (2017-2022)
7.2.5 QIAGEN Key News
7.3 PerkinElmer
7.3.1 PerkinElmer Corporate Summary
7.3.2 PerkinElmer Business Overview
7.3.3 PerkinElmer Metagenomics in Healthcare Major Product Offerings
7.3.4 PerkinElmer Metagenomics in Healthcare Revenue in Global Market (2017-2022)
7.3.5 PerkinElmer Key News
7.4 Thermo Fisher Scientific
7.4.1 Thermo Fisher Scientific Corporate Summary
7.4.2 Thermo Fisher Scientific Business Overview
7.4.3 Thermo Fisher Scientific Metagenomics in Healthcare Major Product Offerings
7.4.4 Thermo Fisher Scientific Metagenomics in Healthcare Revenue in Global Market (2017-2022)
7.4.5 Thermo Fisher Scientific Key News
7.5 Oxford Nanopore Technologies
7.5.1 Oxford Nanopore Technologies Corporate Summary
7.5.2 Oxford Nanopore Technologies Business Overview
7.5.3 Oxford Nanopore Technologies Metagenomics in Healthcare Major Product Offerings
7.5.4 Oxford Nanopore Technologies Metagenomics in Healthcare Revenue in Global Market (2017-2022)
7.5.5 Oxford Nanopore Technologies Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Metagenomics in Healthcare Market Opportunities & Trends in Global Market
Table 2. Metagenomics in Healthcare Market Drivers in Global Market
Table 3. Metagenomics in Healthcare Market Restraints in Global Market
Table 4. Key Players of Metagenomics in Healthcare in Global Market
Table 5. Top Metagenomics in Healthcare Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Metagenomics in Healthcare Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Metagenomics in Healthcare Revenue Share by Companies, 2017-2022
Table 8. Global Companies Metagenomics in Healthcare Product Type
Table 9. List of Global Tier 1 Metagenomics in Healthcare Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Metagenomics in Healthcare Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Metagenomics in Healthcare Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Metagenomics in Healthcare Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Metagenomics in Healthcare Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Metagenomics in Healthcare Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Metagenomics in Healthcare Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Metagenomics in Healthcare Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Metagenomics in Healthcare Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Metagenomics in Healthcare Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Metagenomics in Healthcare Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Metagenomics in Healthcare Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Metagenomics in Healthcare Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Metagenomics in Healthcare Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Metagenomics in Healthcare Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Metagenomics in Healthcare Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Metagenomics in Healthcare Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Metagenomics in Healthcare Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Metagenomics in Healthcare Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Metagenomics in Healthcare Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Metagenomics in Healthcare Revenue, (US$, Mn), 2023-2028
Table 30. Illumina Corporate Summary
Table 31. Illumina Metagenomics in Healthcare Product Offerings
Table 32. Illumina Metagenomics in Healthcare Revenue (US$, Mn), (2017-2022)
Table 33. QIAGEN Corporate Summary
Table 34. QIAGEN Metagenomics in Healthcare Product Offerings
Table 35. QIAGEN Metagenomics in Healthcare Revenue (US$, Mn), (2017-2022)
Table 36. PerkinElmer Corporate Summary
Table 37. PerkinElmer Metagenomics in Healthcare Product Offerings
Table 38. PerkinElmer Metagenomics in Healthcare Revenue (US$, Mn), (2017-2022)
Table 39. Thermo Fisher Scientific Corporate Summary
Table 40. Thermo Fisher Scientific Metagenomics in Healthcare Product Offerings
Table 41. Thermo Fisher Scientific Metagenomics in Healthcare Revenue (US$, Mn), (2017-2022)
Table 42. Oxford Nanopore Technologies Corporate Summary
Table 43. Oxford Nanopore Technologies Metagenomics in Healthcare Product Offerings
Table 44. Oxford Nanopore Technologies Metagenomics in Healthcare Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Metagenomics in Healthcare Segment by Type in 2021
Figure 2. Metagenomics in Healthcare Segment by Application in 2021
Figure 3. Global Metagenomics in Healthcare Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Metagenomics in Healthcare Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Metagenomics in Healthcare Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Metagenomics in Healthcare Revenue in 2021
Figure 8. By Type - Global Metagenomics in Healthcare Revenue Market Share, 2017-2028
Figure 9. By Application - Global Metagenomics in Healthcare Revenue Market Share, 2017-2028
Figure 10. By Region - Global Metagenomics in Healthcare Revenue Market Share, 2017-2028
Figure 11. By Country - North America Metagenomics in Healthcare Revenue Market Share, 2017-2028
Figure 12. US Metagenomics in Healthcare Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Metagenomics in Healthcare Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Metagenomics in Healthcare Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Metagenomics in Healthcare Revenue Market Share, 2017-2028
Figure 16. Germany Metagenomics in Healthcare Revenue, (US$, Mn), 2017-2028
Figure 17. France Metagenomics in Healthcare Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Metagenomics in Healthcare Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Metagenomics in Healthcare Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Metagenomics in Healthcare Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Metagenomics in Healthcare Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Metagenomics in Healthcare Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Metagenomics in Healthcare Revenue Market Share, 2017-2028
Figure 24. China Metagenomics in Healthcare Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Metagenomics in Healthcare Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Metagenomics in Healthcare Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Metagenomics in Healthcare Revenue, (US$, Mn), 2017-2028
Figure 28. India Metagenomics in Healthcare Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Metagenomics in Healthcare Revenue Market Share, 2017-2028
Figure 30. Brazil Metagenomics in Healthcare Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Metagenomics in Healthcare Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Metagenomics in Healthcare Revenue Market Share, 2017-2028
Figure 33. Turkey Metagenomics in Healthcare Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Metagenomics in Healthcare Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Metagenomics in Healthcare Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Metagenomics in Healthcare Revenue, (US$, Mn), 2017-2028
Figure 37. Illumina Metagenomics in Healthcare Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. QIAGEN Metagenomics in Healthcare Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. PerkinElmer Metagenomics in Healthcare Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Thermo Fisher Scientific Metagenomics in Healthcare Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Oxford Nanopore Technologies Metagenomics in Healthcare Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount